Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)
Le Lézard,
This publication validates Adolore's approach for the intracellular delivery of a non-opioid analgesic minigene to targeted…